← Back to Clinical Trials
Recruiting Phase 2 NCT07102836

COMPARISON OF ZINC AND PROBIOTICS ON NEONATES WITH INDIRECT HYPERBILIRUBINEMIA UNDERGOING PHOTOTHERAPY

Trial Parameters

Condition Indirect Hyperbilirubinemia
Sponsor Quaid-e-Azam Medical College
Study Type INTERVENTIONAL
Phase Phase 2
Enrollment 110
Sex ALL
Min Age 0 Days
Max Age 28 Days
Start Date 2025-08-07
Completion 2026-02-07
Interventions
Zinc sulfateProbiotic lactobacillus rhamnosus GG

Brief Summary

Study will evaluate effects of oral zinc and probiotics supplementation in neonates who have indirect hyperbilirubinemia and are receiving phototherapy. Aim is to compare efficacy of these two drugs in clearing bilirubin and reducing duration of phototherapy. Neonates will be randomly assigned to receive either drug alongside phototherapy.

Eligibility Criteria

Inclusion Criteria: * 1\. Term or Near term neonates 2. Age \<7 days at enrollment 3. Bilirubin levels within phototherapy range according to NICE bilirubin threshold charts 4. No identifiable pathology 5. Tolerating oral feeds 6. Parental or Guardian written informed consent taken. Exclusion Criteria: * 1\. Positive sepsis screen or clinical signs of infection 2. Direct hyperbilirubinemia 3. Gastrointestinal malformations 4. Oral intolerance 5. Requiring mechanical ventilation 6. Congenital anomalies 7. Parental or Guardian refusal to participate in study

Related Trials